基于T细胞免疫的通用流感疫苗进展研究综述

Research Overview of Advances in Universal Influenza Vaccines Based on T-Cell Immunity

流行性感冒是一种广泛传播的呼吸道疾病,每年都会导致全球数百万人感染和数十万人死亡。目前的流感疫苗主要依赖于特定病毒株的识别,并且需要经常更新以适应流感病毒的变异。为了应对这一挑战,研究人员致力于开发一种通用流感疫苗,能够提供广谱的保护性免疫反应。本文综述了基于T细胞免疫的通用流感疫苗的最新进展研究。

Influenza, also known as seasonal flu, is a widely spread respiratory disease that infects millions of people and causes hundreds of thousands of deaths worldwide each year. Current influenza vac-cines primarily rely on the recognition of specific viral strains and require regular updates to match the evolving influenza viruses. To address this challenge, researchers have been devoted to devel-oping a universal influenza vaccine that can provide broad-spectrum protective immune responses. This article provides an overview of the latest advances in research on universal influenza vaccines based on T-cell immunity.